Trial intelligence / Profile preview

Intrathecal Dexmedetomidine in Knee Arthroplasty

NCT07807020Phase 2Enrolling by invitation

Sponsor
Shifa International Hospital
Start
May 2026
Primary completion
May 2027
Countries
1
01

Overview

A Phase 2 trial of dexmedetomidine in postoperative pain, sponsored by Shifa International Hospital. Started May 2026; status: enrolling by invitation.

02

Drugs

dexmedetomidine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT07807020.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07807020.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call